Literature DB >> 9774651

The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release.

C A Bradham1, T Qian, K Streetz, C Trautwein, D A Brenner, J J Lemasters.   

Abstract

This study assesses the controversial role of the mitochondrial permeability transition (MPT) in apoptosis. In primary rat hepatocytes expressing an IkappaB superrepressor, tumor necrosis factor alpha (TNFalpha) induced apoptosis as shown by nuclear morphology, DNA ladder formation, and caspase 3 activation. Confocal microscopy showed that TNFalpha induced onset of the MPT and mitochondrial depolarization beginning 9 h after TNFalpha treatment. Initially, depolarization and the MPT occurred in only a subset of mitochondria; however, by 12 h after TNFalpha treatment, virtually all mitochondria were affected. Cyclosporin A (CsA), an inhibitor of the MPT, blocked TNFalpha-mediated apoptosis and cytochrome c release. Caspase 3 activation, cytochrome c release, and apoptotic nuclear morphological changes were induced after onset of the MPT and were prevented by CsA. Depolarization and onset of the MPT were blocked in hepatocytes expressing DeltaFADD, a dominant negative mutant of Fas-associated protein with death domain (FADD), or crmA, a natural serpin inhibitor of caspases. In contrast, Asp-Glu-Val-Asp-cho, an inhibitor of caspase 3, did not block depolarization or onset of the MPT induced by TNFalpha, although it inhibited cell death completely. In conclusion, the MPT is an essential component in the signaling pathway for TNFalpha-induced apoptosis in hepatocytes which is required for both cytochrome c release and cell death and functions downstream of FADD and crmA but upstream of caspase 3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774651      PMCID: PMC109221          DOI: 10.1128/MCB.18.11.6353

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins.

Authors:  M Leist; F Gantner; H Naumann; H Bluethmann; K Vogt; R Brigelius-Flohé; P Nicotera; H D Volk; A Wendel
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

3.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

4.  Inhibition of Bax channel-forming activity by Bcl-2.

Authors:  B Antonsson; F Conti; A Ciavatta; S Montessuit; S Lewis; I Martinou; L Bernasconi; A Bernard; J J Mermod; G Mazzei; K Maundrell; F Gambale; R Sadoul; J C Martinou
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

5.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

6.  The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Authors:  N Roy; Q L Deveraux; R Takahashi; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.

Authors:  H Hsu; J Xiong; D V Goeddel
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

8.  Motional dynamics of functional cytochrome c delivered by low pH fusion into the intermembrane space of intact mitochondria.

Authors:  J D Cortese; C R Hackenbrock
Journal:  Biochim Biophys Acta       Date:  1993-04-05

9.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

Authors:  S A Susin; N Zamzami; M Castedo; T Hirsch; P Marchetti; A Macho; E Daugas; M Geuskens; G Kroemer
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway.

Authors:  G S Dbaibo; D K Perry; C J Gamard; R Platt; G G Poirier; L M Obeid; Y A Hannun
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more
  67 in total

1.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.

Authors:  A A van de Loosdrecht; E Vellenga
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 3.  Mitochondria and apoptosis: HQ or high-security prison?

Authors:  N J Waterhouse; D R Green
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 4.  Mitochondrial function in apoptotic neuronal cell death.

Authors:  Samantha L Budd Haeberlein
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

5.  Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes.

Authors:  Peter Pediaditakis; Jae-Sung Kim; Lihua He; Xun Zhang; Lee M Graves; John J Lemasters
Journal:  Biochem J       Date:  2010-11-01       Impact factor: 3.857

6.  Nuclear factor κB up-regulation of CCAAT/enhancer-binding protein β mediates hepatocyte resistance to tumor necrosis factor α toxicity.

Authors:  Yongjun Wang; Rajat Singh; Youqing Xiang; Linda E Greenbaum; Mark J Czaja
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

7.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

8.  Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Authors:  R Pulmanausahakul; M Faber; K Morimoto; S Spitsin; E Weihe; D C Hooper; M J Schnell; B Dietzschold
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.

Authors:  Shumpei Yokota; Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-12       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.